Coronamonomania Lives Forever, Part 170

If you wonder about excess deaths, here is another example demonstrating that it is due to missed care.  Cancer patients need to be diagnosed early to have good outcomes.  Apparently tens of thousands of people in the UK have missed cancer diagnoses.  The same is likely true in the US.  (DS Story)

Another bad and obvious effect of the CV-19 response, if you make high schoolers “learn” remotely, and remove them from contact and socialization, their mental health deteriorates sharply.  (SSRN Study)

Another study on the origins of CV-19.  Not sure what difference it really makes; China is never going to take responsibility and it certainly isn’t going to stop doing research on modifying respiratory viruses to become weapons.  Neither is Russia, North Korea or Iran.  I hope we are doing our own and figuring out how to stop whatever someone else comes up with.  In any event, this paper is pretty compelling in presenting evidence that CV-19 did have a lab origin.  CV-19 has features around how segments could be moved that are more consistent with synthetic viruses and are not found in other coronaviruses.  (Medrxiv Paper)

The one clear example of a vax side effect is heart inflammation, particularly in younger males.  But it is rare and usually very mild.  This study from Israel finds that among adolescents, heart inflammation following vax was rare and that all cases were mild.  (NEJM Article)

And here is a general research article on myocarditis, or heart inflammation, which will give you good background.  As the article notes, CV-19 is at least as frequently associated with myocarditis as the vax are.  (NEJM Article)

Large population-based study of adolescents in Sweden finds no evidence that vax results in serious adverse events with an increased hospitalization risk.  The study also notes that serious disease in adolescents is extremely rare and additional vax may not be justified for this age group.  (Medrxiv Paper)

But here is a little hope for the vax are unsafe diehards, a study from Japan, very large, finds some increased risk of death involving myocarditis associated with vax.  But out of 100,000,000 people in the study, only 38 myocarditis associated deaths.  And no identification of who had been infected previously, which is a major confounder.  And the pre-epidemic comparison population had myocarditis defined by different standards.  Other than that, a great study.  (Medrxiv Paper)

And another supposed CV-19 treatment bites the dust as a randomized trial finds no evidence that fluoxamine reduces time to recovery.  Fluoxamine was most commonly used as an antidepressant.  But no harm, I guess, in drug companies trying to boost sales by claiming that anything works against CV-19.  (Medrxiv Paper)